Ratings by Citi (Neena Bitritto-Garg)
Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
---|---|---|---|---|---|---|---|---|
2/5/2024 | Sarepta Therapeutics | SRPT | Maintain | Buy (N/A) |
|
Details | ||
7/14/2023 | Acadia Pharmaceuticals | ACAD | Maintain | Neutral (N/A) |
|
Details | ||
6/23/2023 | Sarepta Therapeutics | SRPT | Maintain | Buy (N/A) |
|
Details | ||
5/24/2023 | Sarepta Therapeutics | SRPT | Maintain | Buy (N/A) |
|
Details | ||
5/15/2023 | Sarepta Therapeutics | SRPT | Maintain | Buy (N/A) |
|
Details | ||
5/12/2023 | Amylyx Pharmaceuticals inc. | AMLX | Maintain | Buy (N/A) |
|
Details | ||
4/19/2023 | Neurocrine Bio. | NBIX | Maintain | Buy (N/A) |
|
Details | ||
4/4/2023 | Sarepta Therapeutics | SRPT | Maintain | Buy (N/A) |
|
Details | ||
4/4/2023 | Sarepta Therapeutics | SRPT | New Coverage | Buy (N/A) |
137.83 (129.46) |
-6.07% | Details | |
3/14/2023 | Amylyx Pharmaceuticals inc. | AMLX | Maintain | Buy (N/A) |
|
Details | ||
3/13/2023 | Acadia Pharmaceuticals | ACAD | Maintain | Neutral (N/A) |
|
Details | ||
3/1/2023 | Alector Inc. | ALEC | Maintain | Buy (N/A) |
|
Details | ||
3/1/2023 | Compass Pathways | CMPS | Maintain | Buy (N/A) |
|
Details | ||
2/24/2023 | Prothena Corp | PRTA | Maintain | Buy (N/A) |
|
Details | ||
2/23/2023 | Karuna Therapeutics Inc. | KRTX | Maintain | Buy (N/A) |
|
Details | ||
2/16/2023 | Sage Therapeutics | SAGE | Maintain | Neutral (N/A) |
|
Details | ||
2/7/2023 | Neurocrine Bio. | NBIX | Maintain | Buy (N/A) |
|
Details | ||
1/6/2023 | atai Life Sciences N.V | ATAI | Maintain | Buy (N/A) |
|
Details | ||
1/5/2023 | Roivant Sciences | ROIV | Maintain | Buy (N/A) |
|
Details | ||
11/16/2022 | Pear Therapeutics | PEAR | Maintain | Buy (N/A) |
|
Details | ||
11/15/2022 | Roivant Sciences | ROIV | Maintain | Buy (N/A) |
|
Details | ||
11/11/2022 | Amylyx Pharmaceuticals inc. | AMLX | Maintain | Buy (N/A) |
|
Details | ||
11/10/2022 | Passage Bio Inc. | PASG | Maintain | Buy (N/A) |
|
Details | ||
11/10/2022 | Kodiak Sciences Inc. | KOD | Maintain | Sell (N/A) |
|
Details | ||
11/10/2022 | Decibel Therapeutics Inc | DBTX | Maintain | Buy (N/A) |
|
Details | ||
11/10/2022 | Alector Inc. | ALEC | Maintain | Buy (N/A) |
|
Details | ||
10/24/2022 | Neurocrine Bio. | NBIX | Maintain | Buy (N/A) |
|
Details | ||
10/24/2022 | Prothena Corp | PRTA | Maintain | Buy (N/A) |
|
Details | ||
10/3/2022 | Amylyx Pharmaceuticals inc. | AMLX | Maintain | Buy (N/A) |
|
Details | ||
9/8/2022 | Amylyx Pharmaceuticals inc. | AMLX | Maintain | Buy (N/A) |
|
Details | ||
8/31/2022 | atai Life Sciences N.V | ATAI | Maintain | Buy (N/A) |
|
Details | ||
8/15/2022 | Roivant Sciences | ROIV | Maintain | Buy (N/A) |
|
Details | ||
8/12/2022 | Amylyx Pharmaceuticals inc. | AMLX | Maintain | Buy (N/A) |
|
Details | ||
8/12/2022 | Pear Therapeutics | PEAR | Maintain | Buy (N/A) |
|
Details | ||
8/11/2022 | Prothena Corp | PRTA | Maintain | Buy (N/A) |
|
Details | ||
8/11/2022 | Decibel Therapeutics Inc | DBTX | Maintain | Buy (N/A) |
|
Details | ||
8/8/2022 | Kodiak Sciences Inc. | KOD | Maintain | Sell (N/A) |
|
Details | ||
8/8/2022 | Karuna Therapeutics Inc. | KRTX | Maintain | Buy (N/A) |
|
Details | ||
8/8/2022 | Acadia Pharmaceuticals | ACAD | Downgrade | Neutral (Buy) |
15.62 (18.49) |
18.37% | Details | |
8/5/2022 | Acadia Pharmaceuticals | ACAD | Downgrade | Neutral (Buy) |
15.62 (18.49) |
18.37% | Details | |
8/5/2022 | Neurocrine Bio. | NBIX | Maintain | Buy (N/A) |
|
Details | ||
8/4/2022 | Compass Pathways | CMPS | Maintain | Buy (N/A) |
|
Details | ||
8/2/2022 | Kodiak Sciences Inc. | KOD | Downgrade | Sell (Neutral) |
9.95 (5.26) |
-47.14% | Details | |
6/28/2022 | Roivant Sciences | ROIV | Maintain | Buy (N/A) |
|
Details | ||
6/21/2022 | Acadia Pharmaceuticals | ACAD | Maintain | Buy (N/A) |
|
Details | ||
6/13/2022 | Amylyx Pharmaceuticals inc. | AMLX | Maintain | Buy (N/A) |
|
Details | ||
6/3/2022 | Amylyx Pharmaceuticals inc. | AMLX | Maintain | Buy (N/A) |
|
Details | ||
6/1/2022 | Sage Therapeutics | SAGE | Maintain | Neutral (N/A) |
|
Details | ||
5/25/2022 | Amylyx Pharmaceuticals inc. | AMLX | New Coverage | Buy (N/A) |
8.42 (2.84) |
-66.27% | Details | |
5/17/2022 | Decibel Therapeutics Inc | DBTX | Maintain | Buy (N/A) |
|
Details | ||
5/17/2022 | atai Life Sciences N.V | ATAI | Maintain | Buy (N/A) |
|
Details | ||
5/17/2022 | Passage Bio Inc. | PASG | Maintain | Buy (N/A) |
|
Details | ||
5/17/2022 | Pear Therapeutics | PEAR | Maintain | Buy (N/A) |
|
Details | ||
5/16/2022 | Prothena Corp | PRTA | Maintain | Neutral (N/A) |
|
Details | ||
4/4/2022 | Alpha Tau Medical Ltd. | DRTS | New Coverage | Buy (N/A) |
10.54 (2.95) |
-72.01% | Details | |
3/29/2022 | Pear Therapeutics | PEAR | Maintain | Buy (N/A) |
|
Details | ||
2/25/2022 | Alector Inc. | ALEC | Maintain | Buy (N/A) |
|
Details | ||
2/25/2022 | Karuna Therapeutics Inc. | KRTX | Maintain | Buy (N/A) |
|
Details | ||
2/24/2022 | Kodiak Sciences Inc. | KOD | Maintain | Neutral (N/A) |
|
Details | ||
1/26/2022 | Kodiak Sciences Inc. | KOD | Maintain | Neutral (N/A) |
|
Details | ||
1/5/2022 | Acadia Pharmaceuticals | ACAD | Upgrade | Buy (Neutral) |
24.39 (18.49) |
-24.19% | Details | |
12/29/2021 | Pear Therapeutics | PEAR | New Coverage | Buy (N/A) |
5.09 (0.03) |
-99.41% | Details | |
12/21/2021 | Acadia Pharmaceuticals | ACAD | Maintain | Neutral (N/A) |
|
Details | ||
12/8/2021 | Neurocrine Bio. | NBIX | Maintain | Buy (N/A) |
|
Details | ||
12/7/2021 | Acadia Pharmaceuticals | ACAD | Maintain | Neutral (N/A) |
|
Details | ||
11/11/2021 | Kodiak Sciences Inc. | KOD | Maintain | Neutral (N/A) |
|
Details | ||
11/11/2021 | Decibel Therapeutics Inc | DBTX | Maintain | Buy (N/A) |
|
Details | ||
11/11/2021 | Cortexyme Inc. | CRTX | Maintain | Sell (N/A) |
|
Details | ||
11/9/2021 | Acadia Pharmaceuticals | ACAD | Maintain | Neutral (N/A) |
|
Details | ||
11/5/2021 | Zogenix, Inc. | ZGNX | Maintain | Neutral (N/A) |
|
Details | ||
11/2/2021 | Neurocrine Bio. | NBIX | Maintain | Buy (N/A) |
|
Details | ||
10/27/2021 | Cortexyme Inc. | CRTX | Maintain | Sell (N/A) |
|
Details | ||
9/27/2021 | Cortexyme Inc. | CRTX | Maintain | Sell (N/A) |
|
Details | ||
8/30/2021 | Karuna Therapeutics Inc. | KRTX | New Coverage | Buy (N/A) |
115.00 (329.83) |
186.81% | Details | |
8/10/2021 | Longboard Pharmaceuticals Inc | LBPH | Maintain | Buy (N/A) |
|
Details | ||
8/6/2021 | Zogenix, Inc. | ZGNX | Maintain | Neutral (N/A) |
|
Details | ||
7/13/2021 | atai Life Sciences N.V | ATAI | New Coverage | Buy (N/A) |
19.00 (1.97) |
-89.63% | Details | |
7/13/2021 | Compass Pathways | CMPS | New Coverage | Buy (N/A) |
36.65 (8.32) |
-77.3% | Details | |
7/5/2021 | Alector Inc. | ALEC | Maintain | Buy (N/A) |
|
Details | ||
6/16/2021 | Sage Therapeutics | SAGE | Downgrade | Neutral (Buy) |
72.86 (18.74) |
-74.28% | Details | |
5/26/2021 | Prothena Corp | PRTA | New Coverage | Buy (N/A) |
25.05 (24.77) |
-1.12% | Details | |
5/7/2021 | Zogenix, Inc. | ZGNX | Maintain | Neutral (N/A) |
|
Details | ||
4/27/2021 | Arena Pharma | ARNA | New Coverage | Buy (N/A) |
68.75 (99.98) |
45.43% | Details | |
4/6/2021 | Longboard Pharmaceuticals Inc | LBPH | New Coverage | Buy (N/A) |
16.04 (20.18) |
25.81% | Details | |
4/5/2021 | Acadia Pharma | ACAD | Maintain | Neutral (N/A) |
|
Details | ||
3/9/2021 | Acadia Pharmaceuticals | ACAD | Downgrade | Neutral (Buy) |
45.78 (18.49) |
-59.61% | Details | |
3/9/2021 | Decibel Therapeutics Inc | DBTX | New Coverage | Buy (N/A) |
14.68 (4.91) |
-66.55% | Details | |
2/24/2021 | Sage Therapeutics | SAGE | Maintain | Buy (N/A) |
|
Details | ||
1/25/2021 | Passage Bio Inc. | PASG | Upgrade | Buy (Neutral) |
19.81 (1.35) |
-93.19% | Details | |
1/11/2021 | Zogenix, Inc. | ZGNX | Maintain | Neutral (Neutral) |
|
Details | ||
1/6/2021 | Sage Therapeutics | SAGE | Maintain | Buy (N/A) |
|
Details | ||
12/16/2020 | Prevail Therapeutics | PRVL | Downgrade | Neutral (Buy) |
12.50 (23.00) |
84% | Details | |
12/11/2020 | Cortexyme Inc. | CRTX | New Coverage | Sell (N/A) |
36.19 (1.95) |
-94.61% | Details | |
12/11/2020 | Kodiak Sciences Inc. | KOD | New Coverage | Neutral (N/A) |
124.11 (5.26) |
-95.76% | Details | |
12/11/2020 | Passage Bio Inc. | PASG | New Coverage | Neutral (N/A) |
27.72 (1.35) |
-95.13% | Details | |
12/1/2020 | Sage Therapeutics | SAGE | Maintain | Buy (N/A) |
|
Details | ||
11/11/2020 | Alector Inc. | ALEC | Maintain | Buy (N/A) |
|
Details | ||
11/10/2020 | Neurocrine Bio. | NBIX | Maintain | Buy (N/A) |
|
Details | ||
7/21/2020 | Acadia Pharmaceuticals | ACAD | Maintain | Buy (N/A) |
|
Details | ||
6/26/2020 | Zogenix, Inc. | ZGNX | Maintain | Neutral (N/A) |
|
Details | ||
6/26/2020 | Neurocrine Bio. | NBIX | Maintain | Buy (N/A) |
|
Details | ||
4/8/2020 | Sage Therapeutics | SAGE | Maintain | Buy (N/A) |
|
Details | ||
3/19/2020 | Sage Therapeutics | SAGE | Maintain | Buy (N/A) |
|
Details | ||
3/19/2020 | Sage Therapeutics | SAGE | Maintain | Buy (N/A) |
|
Details | ||
3/6/2020 | Zogenix, Inc. | ZGNX | New Coverage | Neutral (N/A) |
27.36 (26.68) |
-2.49% | Details | |
3/6/2020 | Sage Therapeutics | SAGE | New Coverage | Buy (N/A) |
53.23 (18.74) |
-64.79% | Details | |
3/6/2020 | Neurocrine Bio. | NBIX | New Coverage | Buy (N/A) |
98.30 (137.92) |
40.31% | Details | |
3/6/2020 | Alector Inc. | ALEC | New Coverage | Buy (N/A) |
31.34 (6.02) |
-80.79% | Details | |
3/6/2020 | Acadia Pharmaceuticals | ACAD | New Coverage | Buy (N/A) |
44.53 (45.78) |
2.81% | Details | |
3/6/2020 | GW Pharma | GWPH | New Coverage | Buy (N/A) |
102.93 (218.96) |
112.73% | Details | |
3/5/2020 | Prevail Therapeutics | PRVL | New Coverage | Buy (N/A) |
16.55 (23.00) |
38.97% | Details |